FREE SHIPPING over $40
OVER 9000 FIVE-STAR REVIEWS
5% OFF ALL SUBSCRIPTIONS
100% HAPPINESS GUARANTEE
Analyze Diet
0
Home / Equine Research Bank / Biomolecules / Differential Expression of ARG1 and MRC2 in Retinal Müller ...
Biomolecules2025; 15(2); 288; doi: 10.3390/biom15020288

Differential Expression of ARG1 and MRC2 in Retinal Müller Glial Cells During Autoimmune Uveitis.

Abstract: Retinal Müller glial cells (RMG) play a crucial role in retinal neuroinflammation, including autoimmune uveitis. Increasing evidence supports their function as active modulators of immune responses and potential atypical antigen-presenting cells (APCs). To further investigate this hypothesis, we conducted a differential proteome analysis of primary equine RMG from healthy controls and horses with equine recurrent uveitis (ERU), a spontaneous model of autoimmune uveitis. This analysis identified 310 proteins with differential abundance. Among these, the Major Histocompatibility Complex (MHC) class II and the enzyme Arginase 1 (ARG1) were significantly enriched in RMG from uveitis-affected horses, whereas Mannose Receptor C-type 2 (MRC2) and its interactor Thrombospondin 1 (THBS1) were more abundant in healthy RMG. The detection of MHC class II in equine RMG, consistent with previous studies, validates the robustness of our approach. Furthermore, the identification of ARG1 and MRC2, together with THBS1, provides new insights into the immunomodulatory and antigen-presenting properties of RMG. Immunohistochemical analyses confirmed the proteomic findings and revealed the spatial distribution of ARG1 and MRC2. ARG1 and MRC2 are thus markers for RMG in the neuroinflammatory or physiological milieu and highlight potential differences in the immune function of RMG, particularly in antigen presentation.
Get Full Text
Publication Date: 2025-02-14 PubMed ID: 40001591PubMed Central: PMC11853277DOI: 10.3390/biom15020288Google Scholar: Lookup
The Equine Research Bank provides access to a large database of publicly available scientific literature. Inclusion in the Research Bank does not imply endorsement of study methods or findings by Mad Barn.
LinkedInCopy
  • Journal Article

Summary

This research summary has been generated with artificial intelligence and may contain errors and omissions. Refer to the original study to confirm details provided. Submit correction.

Overview

  • This study explored protein expression differences in retinal Müller glial cells (RMG) between healthy eyes and those affected by autoimmune uveitis, focusing on how RMG cells may participate in immune responses within the retina.

Background

  • Retinal Müller glial cells are specialized support cells within the retina, essential for maintaining retinal structure and function.
  • Beyond their supportive roles, RMG cells are increasingly recognized as active players in retinal neuroinflammation, including autoimmune uveitis, a condition characterized by inflammation within the eye.
  • There is mounting evidence that RMG cells might also function as atypical antigen-presenting cells (APCs), potentially influencing immune activation or regulation in the retina.
  • Equine recurrent uveitis (ERU) is a naturally occurring model of autoimmune uveitis, making horses a valuable system to study disease mechanisms applicable to human uveitis.

Research Objective

  • The aim was to characterize differential protein expression in primary RMG cells isolated from healthy horses and those with ERU to identify proteins involved in immune modulation and antigen presentation.
  • The goal was to further understand the role of RMG cells in neuroinflammation and their potential immunomodulatory functions.

Methodology

  • Primary RMG cells were harvested from equine retinas of both healthy control horses and those affected by ERU.
  • A differential proteome analysis (likely involving mass spectrometry) was carried out to detect and quantify proteins expressed in RMG cells from the two groups.
  • Proteins showing significant differences in abundance between healthy and diseased conditions were identified and analyzed.
  • Immunohistochemical analyses were conducted to validate proteomic data and to determine the spatial distribution of key proteins within retinal tissues.

Main Findings

  • A total of 310 proteins exhibited differential abundance between healthy and uveitis-affected RMG cells.
  • Proteins significantly enriched in RMG from uveitis-affected horses included:
    • Major Histocompatibility Complex (MHC) class II molecules, known for their key role in antigen presentation to immune cells.
    • Arginase 1 (ARG1), an enzyme involved in immune regulation by modulating arginine metabolism and affecting immune cell function.
  • Proteins more abundant in healthy RMG cells included:
    • Mannose Receptor C-type 2 (MRC2), a receptor involved in cellular adhesion and endocytosis, often implicated in extracellular matrix remodeling and possibly immune functions.
    • Thrombospondin 1 (THBS1), a protein that interacts with MRC2 and is involved in cell communication, tissue repair, and immunomodulation.
  • The presence of MHC class II molecules in RMG cells confirmed their potential role as antigen-presenting cells, consistent with previous studies and validating the experimental approach.
  • ARG1 and MRC2, along with THBS1, represent novel markers in RMG cells for distinguishing their functional states under inflammatory (uveitis) versus normal conditions.

Interpretation and Implications

  • The enrichment of MHC class II and ARG1 in RMG from uveitic eyes suggests these glial cells may actively present antigens and modulate immune responses during retinal inflammation.
  • The decreased abundance of MRC2 and THBS1 in uveitis suggests a shift in RMG function or phenotype under inflammatory conditions compared to their physiological state.
  • These proteins (ARG1 and MRC2) could serve as markers to distinguish RMG involvement in neuroinflammation versus normal retinal function.
  • Understanding this differential expression provides deeper insight into how RMG cells contribute to immune regulation and potentially to the pathogenesis or resolution of autoimmune uveitis.
  • These findings may contribute to identifying new therapeutic targets aimed at modulating RMG function to treat or prevent retinal inflammation.

Conclusion

  • The study demonstrates distinct changes in protein expression in retinal Müller glial cells during autoimmune uveitis, highlighting their dual role as immune modulators and potential antigen-presenting cells.
  • ARG1 and MRC2 are promising markers reflecting the immune environment of the retina and the functional status of RMG cells.
  • This research adds valuable knowledge toward comprehending neuroinflammatory mechanisms within the retina and could guide future therapeutic strategies for uveitis and related eye diseases.

Cite This Article

APA
Fleischer AB, Amann B, von Toerne C, Degroote RL, Schmalen A, Weißer T, Hauck SM, Deeg CA. (2025). Differential Expression of ARG1 and MRC2 in Retinal Müller Glial Cells During Autoimmune Uveitis. Biomolecules, 15(2), 288. https://doi.org/10.3390/biom15020288

Publication

Biomolecules
ISSN: 2218-273X
NlmUniqueID: 101596414
Country: Switzerland
Language: English
Volume: 15
Issue: 2
PII: 288

Researcher Affiliations

Fleischer, Amelie B
  • Chair of Physiology, Department of Veterinary Sciences, LMU Munich, D-82152 Martinsried, Germany.
Amann, Barbara
  • Chair of Physiology, Department of Veterinary Sciences, LMU Munich, D-82152 Martinsried, Germany.
von Toerne, Christine
  • Metabolomics and Proteomics Core, Helmholtz Center Munich, German Research Center for Environmental Health, D-80939 Munich, Germany.
Degroote, Roxane L
  • Chair of Physiology, Department of Veterinary Sciences, LMU Munich, D-82152 Martinsried, Germany.
Schmalen, Adrian
  • Chair of Physiology, Department of Veterinary Sciences, LMU Munich, D-82152 Martinsried, Germany.
Weißer, Tanja
  • Chair of Physiology, Department of Veterinary Sciences, LMU Munich, D-82152 Martinsried, Germany.
Hauck, Stefanie M
  • Metabolomics and Proteomics Core, Helmholtz Center Munich, German Research Center for Environmental Health, D-80939 Munich, Germany.
Deeg, Cornelia A
  • Chair of Physiology, Department of Veterinary Sciences, LMU Munich, D-82152 Martinsried, Germany.

MeSH Terms

  • Animals
  • Horses
  • Uveitis / metabolism
  • Uveitis / veterinary
  • Uveitis / pathology
  • Uveitis / immunology
  • Uveitis / genetics
  • Autoimmune Diseases / metabolism
  • Autoimmune Diseases / veterinary
  • Autoimmune Diseases / pathology
  • Arginase / metabolism
  • Arginase / genetics
  • Horse Diseases / metabolism
  • Ependymoglial Cells / metabolism
  • Ependymoglial Cells / pathology
  • Thrombospondin 1 / metabolism
  • Retina / metabolism
  • Retina / pathology
  • Proteomics
  • Proteome

Grant Funding

  • DFG DE719/7-1 in SPP 2127 / Deutsche Forschungsgemeinschaft

Conflict of Interest Statement

The authors declare no conflicts of interest.

References

This article includes 142 references
  1. Li Y, Zhu L, Cai M.X, Wang Z.L, Zhuang M, Tan C.Y, Xie T.H, Yao Y, Wei T.T. TGR5 supresses cGAS/STING pathway by inhibiting GRP75-mediated endoplasmic reticulum-mitochondrial coupling in diabetic retinopathy.. Cell Death Dis 2023;14:583.
    doi: 10.1038/s41419-023-06111-5pmc: PMC10474119pubmed: 37658045google scholar: lookup
  2. Lai D, Wu Y, Shao C, Qiu Q. The Role of Müller Cells in Diabetic Macular Edema.. Investig. Ophthalmol. Vis. Sci. 2023;64:8.
    doi: 10.1167/iovs.64.10.8pmc: PMC10337800pubmed: 37418272google scholar: lookup
  3. Hu X, Zhao G.L, Xu M.X, Zhou H, Li F, Miao Y, Lei B, Yang X.L, Wang Z. Interplay between Müller cells and microglia aggravates retinal inflammatory response in experimental glaucoma.. J. Neuroinflamm. 2021;18:303.
    doi: 10.1186/s12974-021-02366-xpmc: PMC8705189pubmed: 34952606google scholar: lookup
  4. Tabor S.J, Yuda K, Deck J, Gnanaguru G, Connor K.M. Retinal Injury Activates Complement Expression in Müller Cells Leading to Neuroinflammation and Photoreceptor Cell Death.. Cells 2023;12:1754.
    doi: 10.3390/cells12131754pmc: PMC10340218pubmed: 37443787google scholar: lookup
  5. Pereiro X, Ruzafa N, Azkargorta M, Elortza F, Acera A, Ambrósio A.F, Santiago A.R, Vecino E. Müller glial cells located in the peripheral retina are more susceptible to high pressure: Implications for glaucoma.. Cell Biosci 2024;14:5.
    doi: 10.1186/s13578-023-01186-1pmc: PMC10770903pubmed: 38183095google scholar: lookup
  6. Wang Y, Yang X, Li Q, Zhang Y, Chen L, Hong L, Xie Z, Yang S, Deng X, Cao M. Single-cell RNA sequencing reveals the Müller subtypes and inner blood-retinal barrier regulatory network in early diabetic retinopathy.. Front. Mol. Neurosci. 2022;15:1048634.
    doi: 10.3389/fnmol.2022.1048634pmc: PMC9754943pubmed: 36533134google scholar: lookup
  7. Eberhardt C, Amann B, Feuchtinger A, Hauck S.M, Deeg C.A. Differential expression of inwardly rectifying K+ channels and aquaporins 4 and 5 in autoimmune uveitis indicates misbalance in Muller glial cell-dependent ion and water homeostasis.. Glia 2011;59:697–707.
    doi: 10.1002/glia.21139pubmed: 21305615google scholar: lookup
  8. Reichenbach A, Bringmann A. New functions of Müller cells.. Glia 2013;61:651–678.
    doi: 10.1002/glia.22477pubmed: 23440929google scholar: lookup
  9. Reichenbach A, Bringmann A. Glia of the human retina.. Glia 2020;68:768–796.
    doi: 10.1002/glia.23727pubmed: 31793693google scholar: lookup
  10. Bringmann A, Pannicke T, Biedermann B, Francke M, Iandiev I, Grosche J, Wiedemann P, Albrecht J, Reichenbach A. Role of retinal glial cells in neurotransmitter uptake and metabolism.. Neurochem. Int. 2009;54:143–160.
    doi: 10.1016/j.neuint.2008.10.014pubmed: 19114072google scholar: lookup
  11. Augustine J, Pavlou S, Harkin K, Stitt A.W, Xu H, Chen M. IL-33 regulates Müller cell-mediated retinal inflammation and neurodegeneration in diabetic retinopathy.. Dis. Model. Mech. 2023;16:dmm050174.
    doi: 10.1242/dmm.050174pmc: PMC10499035pubmed: 37671525google scholar: lookup
  12. Bringmann A, Iandiev I, Pannicke T, Wurm A, Hollborn M, Wiedemann P, Osborne N.N, Reichenbach A. Cellular signaling and factors involved in Müller cell gliosis: Neuroprotective and detrimental effects.. Prog. Retin. Eye Res. 2009;28:423–451.
    doi: 10.1016/j.preteyeres.2009.07.001pubmed: 19660572google scholar: lookup
  13. Peña J.S, Vazquez M. Harnessing the Neuroprotective Behaviors of Müller Glia for Retinal Repair.. Front. Biosci. 2022;27:169.
    doi: 10.31083/j.fbl2706169pmc: PMC9639582pubmed: 35748245google scholar: lookup
  14. Mahaling B, Sinha N.R, Sokupa S, Addi U.R, Mohan R.R, Chaurasia S.S. Mustard gas exposure instigates retinal Müller cell gliosis.. Exp. Eye Res. 2023;230:109461.
    doi: 10.1016/j.exer.2023.109461pmc: PMC10157651pubmed: 37023936google scholar: lookup
  15. Vecino E, Rodriguez F.D, Ruzafa N, Pereiro X, Sharma S.C. Glia–neuron interactions in the mammalian retina.. Prog. Retin. Eye Res. 2016;51:1–40.
    doi: 10.1016/j.preteyeres.2015.06.003pubmed: 26113209google scholar: lookup
  16. Hauck S.M., Schoeffmann S., Amann B., Stangassinger M., Gerhards H., Ueffing M., Deeg C.A. Retinal Mueller glial cells trigger the hallmark inflammatory process in autoimmune uveitis. J. Proteome Res. 2007;6:2121–2131. doi: 10.1021/pr060668y.
    doi: 10.1021/pr060668ypubmed: 17444670google scholar: lookup
  17. Schmalen A., Lorenz L., Grosche A., Pauly D., Deeg C.A., Hauck S.M. Proteomic Phenotyping of Stimulated Muller Cells Uncovers Profound Pro-Inflammatory Signaling and Antigen-Presenting Capacity. Front. Pharmacol. 2021;12:771571. doi: 10.3389/fphar.2021.771571.
    doi: 10.3389/fphar.2021.771571pmc: PMC8585775pubmed: 34776983google scholar: lookup
  18. Drescher K.M., Whittum-Hudson J.A. Modulation of immune-associated surface markers and cytokine production by murine retinal glial cells. J. Neuroimmunol. 1996;64:71–81. doi: 10.1016/0165-5728(95)00156-5.
    doi: 10.1016/0165-5728(95)00156-5pmc: PMC7119802pubmed: 8598392google scholar: lookup
  19. Singh P.K., Shiha M.J., Kumar A. Antibacterial responses of retinal Müller glia: Production of antimicrobial peptides, oxidative burst and phagocytosis. J. Neuroinflamm. 2014;11:33. doi: 10.1186/1742-2094-11-33.
    doi: 10.1186/1742-2094-11-33pmc: PMC3937076pubmed: 24548736google scholar: lookup
  20. Kumar A., Shamsuddin N. Retinal Muller glia initiate innate response to infectious stimuli via toll-like receptor signaling. PLoS ONE. 2012;7:e29830. doi: 10.1371/journal.pone.0029830.
    doi: 10.1371/journal.pone.0029830pmc: PMC3253788pubmed: 22253793google scholar: lookup
  21. Shamsuddin N., Kumar A. TLR2 mediates the innate response of retinal Muller glia to Staphylococcus aureus. J. Immunol. 2011;186:7089–7097. doi: 10.4049/jimmunol.1100565.
    doi: 10.4049/jimmunol.1100565pmc: PMC3110513pubmed: 21602496google scholar: lookup
  22. Natoli R., Fernando N., Madigan M., Chu-Tan J.A., Valter K., Provis J., Rutar M. Microglia-derived IL-1β promotes chemokine expression by Müller cells and RPE in focal retinal degeneration. Mol. Neurodegener. 2017;12:31. doi: 10.1186/s13024-017-0175-y.
    doi: 10.1186/s13024-017-0175-ypmc: PMC5404662pubmed: 28438165google scholar: lookup
  23. Rutar M., Natoli R., Chia R.X., Valter K., Provis J.M. Chemokine-mediated inflammation in the degenerating retina is coordinated by Müller cells, activated microglia, and retinal pigment epithelium. J. Neuroinflamm. 2015;12:8. doi: 10.1186/s12974-014-0224-1.
    doi: 10.1186/s12974-014-0224-1pmc: PMC4308937pubmed: 25595590google scholar: lookup
  24. Bejarano-Escobar R., Sánchez-Calderón H., Otero-Arenas J., Martín-Partido G., Francisco-Morcillo J. Müller glia and phagocytosis of cell debris in retinal tissue. J. Anat. 2017;231:471–483. doi: 10.1111/joa.12653.
    doi: 10.1111/joa.12653pmc: PMC5603788pubmed: 28695619google scholar: lookup
  25. Morales M., Findley A.P., Mitchell D.M. Intercellular contact and cargo transfer between Müller glia and to microglia precede apoptotic cell clearance in the developing retina. Development. 2024;151:dev202407. doi: 10.1242/dev.202407.
    doi: 10.1242/dev.202407pmc: PMC10820749pubmed: 38174987google scholar: lookup
  26. Tsirouki T., Dastiridou A., Symeonidis C., Tounakaki O., Brazitikou I., Kalogeropoulos C., Androudi S. A Focus on the Epidemiology of Uveitis. Ocul. Immunol. Inflamm. 2018;26:2–16. doi: 10.1080/09273948.2016.1196713.
    doi: 10.1080/09273948.2016.1196713pubmed: 27467180google scholar: lookup
  27. Huang C., Zhang Z., Gu J., Li D., Gao S., Zhang R., Shi R., Sun J. Combined Therapy of Experimental Autoimmune Uveitis by a Dual-Drug Nanocomposite Formulation with Berberine and Dexamethasone. Int. J. Nanomed. 2023;18:4347–4363. doi: 10.2147/IJN.S417750.
    doi: 10.2147/IJN.S417750pmc: PMC10402891pubmed: 37545873google scholar: lookup
  28. Zhang M., Zhang X. T cells in ocular autoimmune uveitis: Pathways and therapeutic approaches. Int. Immunopharmacol. 2023;114:109565. doi: 10.1016/j.intimp.2022.109565.
    doi: 10.1016/j.intimp.2022.109565pubmed: 36535124google scholar: lookup
  29. Gerding J.C., Gilger B.C. Prognosis and impact of equine recurrent uveitis. Equine Vet. J. 2016;48:290–298. doi: 10.1111/evj.12451.
    doi: 10.1111/evj.12451pubmed: 25891653google scholar: lookup
  30. Spiess B.M. Equine recurrent uveitis: The European viewpoint. Equine Vet. J. 2010;42:50–56. doi: 10.1111/j.2042-3306.2010.tb05635.x.
    doi: 10.1111/j.2042-3306.2010.tb05635.xpubmed: 20939167google scholar: lookup
  31. Cassano J.M., Leonard B.C., Martins B.C., Vapniarsky N., Morgan J.T., Dow S.W., Wotman K.L., Pezzanite L.M. Preliminary evaluation of safety and migration of immune activated mesenchymal stromal cells administered by subconjunctival injection for equine recurrent uveitis. Front. Vet. Sci. 2023;10:1293199. doi: 10.3389/fvets.2023.1293199.
    doi: 10.3389/fvets.2023.1293199pmc: PMC10757620pubmed: 38162475google scholar: lookup
  32. Deeg C.A., Hauck S.M., Amann B., Pompetzki D., Altmann F., Raith A., Schmalzl T., Stangassinger M., Ueffing M. Equine recurrent uveitis--a spontaneous horse model of uveitis. Ophthalmic Res. 2008;40:151–153. doi: 10.1159/000119867.
    doi: 10.1159/000119867pubmed: 18421230google scholar: lookup
  33. Deeg C.A., Raith A.J., Amann B., Crabb J.W., Thurau S.R., Hauck S.M., Ueffing M., Wildner G., Stangassinger M. CRALBP is a highly prevalent autoantigen for human autoimmune uveitis. Clin. Dev. Immunol. 2007;2007:39245. doi: 10.1155/2007/39245.
    doi: 10.1155/2007/39245pmc: PMC2246040pubmed: 18317528google scholar: lookup
  34. Söth R., Hoffmann A.L.C., Deeg C.A. Enhanced ROS Production and Mitochondrial Metabolic Shifts in CD4+ T Cells of an Autoimmune Uveitis Model. Int. J. Mol. Sci. 2024;25:11513. doi: 10.3390/ijms252111513.
    doi: 10.3390/ijms252111513pmc: PMC11545935pubmed: 39519064google scholar: lookup
  35. Karagianni A.E., Lisowski Z.M., Hume D.A., Scott Pirie R. The equine mononuclear phagocyte system: The relevance of the horse as a model for understanding human innate immunity. Equine Vet. J. 2021;53:231–249. doi: 10.1111/evj.13341.
    doi: 10.1111/evj.13341pubmed: 32881079google scholar: lookup
  36. Horohov D.W. The equine immune responses to infectious and allergic disease: A model for humans? Mol. Immunol. 2015;66:89–96. doi: 10.1016/j.molimm.2014.09.020.
    doi: 10.1016/j.molimm.2014.09.020pubmed: 25457878google scholar: lookup
  37. Gilger B.C. Immune Relevant Models for Ocular Inflammatory Diseases. ILAR J. 2018;59:352–362. doi: 10.1093/ilar/ily002.
    doi: 10.1093/ilar/ily002pubmed: 29474707google scholar: lookup
  38. Nussenblatt R.B., Gery I., Ballintine E.J., Wacker W.B. Cellular Immune Responsiveness of Uveitis Patients to Retinal S-Antigen. Am. J. Ophthalmol. 1980;89:173–179. doi: 10.1016/0002-9394(80)90108-7.
    doi: 10.1016/0002-9394(80)90108-7pubmed: 7355973google scholar: lookup
  39. Caspi R.R., Roberge F.G., Chan C.C., Wiggert B., Chader G.J., Rozenszajn L.A., Lando Z., Nussenblatt R.B. A new model of autoimmune disease. Experimental autoimmune uveoretinitis induced in mice with two different retinal antigens. J. Immunol. 1988;140:1490–1495. doi: 10.4049/jimmunol.140.5.1490.
    doi: 10.4049/jimmunol.140.5.1490pubmed: 3346541google scholar: lookup
  40. Kozak Y.d., Sakai J., Thillaye B., Faure J.P. S antigen-induced experimental autoimmune uveo-retinitis in rats. Curr. Eye Res. 1981;1:327–337. doi: 10.3109/02713688108998359.
    doi: 10.3109/02713688108998359pubmed: 6975701google scholar: lookup
  41. Romeike A., Brügmann M., Drommer W. Immunohistochemical studies in equine recurrent uveitis (ERU) Vet. Pathol. 1998;35:515–526. doi: 10.1177/030098589803500606.
    doi: 10.1177/030098589803500606pubmed: 9823593google scholar: lookup
  42. Gilger B.C., Malok E., Cutter K.V., Stewart T., Horohov D.W., Allen J.B. Characterization of T-lymphocytes in the anterior uvea of eyes with chronic equine recurrent uveitis. Vet. Immunol. Immunopathol. 1999;71:17–28. doi: 10.1016/S0165-2427(99)00082-3.
    doi: 10.1016/S0165-2427(99)00082-3pubmed: 10522783google scholar: lookup
  43. Deeg C.A., Kaspers B., Gerhards H., Thurau S.R., Wollanke B., Wildner G. Immune responses to retinal autoantigens and peptides in equine recurrent uveitis. Investig. Ophthalmol. Vis. Sci. 2001;42:393–398.
    pubmed: 11157872
  44. Deeg C.A., Pompetzki D., Raith A.J., Hauck S.M., Amann B., Suppmann S., Goebel T.W.F., Olazabal U., Gerhards H., Reese S., et al. Identification and Functional Validation of Novel Autoantigens in Equine Uveitis. Mol. Cell. Proteom. 2006;5:1462–1470. doi: 10.1074/mcp.M500352-MCP200.
    doi: 10.1074/mcp.M500352-MCP200pubmed: 16690753google scholar: lookup
  45. Deeg C.A., Hauck S.M., Amann B., Kremmer E., Stangassinger M., Ueffing M. Major retinal autoantigens remain stably expressed during all stages of spontaneous uveitis. Mol. Immunol. 2007;44:3291–3296. doi: 10.1016/j.molimm.2007.02.027.
    doi: 10.1016/j.molimm.2007.02.027pubmed: 17467057google scholar: lookup
  46. McPherson S.W., Heuss N.D., Abedin M., Roehrich H., Pierson M.J., Gregerson D.S. Parabiosis reveals the correlation between the recruitment of circulating antigen presenting cells to the retina and the induction of spontaneous autoimmune uveoretinitis. J. Neuroinflamm. 2022;19:295. doi: 10.1186/s12974-022-02660-2.
    doi: 10.1186/s12974-022-02660-2pmc: PMC9733026pubmed: 36494807google scholar: lookup
  47. Xiao R., Huang X., Gao S., Duan J., Zhang Y., Zhang M. Microglia in retinal diseases: From pathogenesis towards therapeutic strategies. Biochem. Pharmacol. 2024;230:116550. doi: 10.1016/j.bcp.2024.116550.
    doi: 10.1016/j.bcp.2024.116550pubmed: 39307318google scholar: lookup
  48. Lipski D.A., Dewispelaere R., Foucart V., Caspers L.E., Defrance M., Bruyns C., Willermain F. MHC class II expression and potential antigen-presenting cells in the retina during experimental autoimmune uveitis. J. Neuroinflamm. 2017;14:136. doi: 10.1186/s12974-017-0915-5.
    doi: 10.1186/s12974-017-0915-5pmc: PMC5516361pubmed: 28720143google scholar: lookup
  49. Okunuki Y., Mukai R., Nakao T., Tabor S.J., Butovsky O., Dana R., Ksander B.R., Connor K.M. Retinal microglia initiate neuroinflammation in ocular autoimmunity. Proc. Natl. Acad. Sci. USA. 2019;116:9989–9998. doi: 10.1073/pnas.1820387116.
    doi: 10.1073/pnas.1820387116pmc: PMC6525481pubmed: 31023885google scholar: lookup
  50. Quinn J., Salman A., Paluch C., Jackson-Wood M., McClements M.E., Luo J., Davis S.J., Cornall R.J., MacLaren R.E., Dendrou C.A., et al. Single-cell transcriptomic analysis of retinal immune regulation and blood-retinal barrier function during experimental autoimmune uveitis. Sci. Rep. 2024;14:20033. doi: 10.1038/s41598-024-68401-y.
    doi: 10.1038/s41598-024-68401-ypmc: PMC11358488pubmed: 39198470google scholar: lookup
  51. Yuan F., Zhang R., Li J., Lei Q., Wang S., Jiang F., Guo Y., Xiang M. CCR5-overexpressing mesenchymal stem cells protect against experimental autoimmune uveitis: Insights from single-cell transcriptome analysis. J. Neuroinflamm. 2024;21:136. doi: 10.1186/s12974-024-03134-3.
    doi: 10.1186/s12974-024-03134-3pmc: PMC11131209pubmed: 38802924google scholar: lookup
  52. Kim M.K., Chan C.C., Belfort R., Jr., Farah M., Burnier M.P., Nussenblatt R.B., Kuwabara T., Palestine A.G. Histopathologic and immunohistopathologic features of subretinal fibrosis and uveitis syndrome. Am. J. Ophthalmol. 1987;104:15–23. doi: 10.1016/0002-9394(87)90287-X.
    doi: 10.1016/0002-9394(87)90287-Xpubmed: 3496794google scholar: lookup
  53. Lorenz L., Hirmer S., Schmalen A., Hauck S.M., Deeg C.A. Cell Surface Profiling of Retinal Muller Glial Cells Reveals Association to Immune Pathways after LPS Stimulation. Cells. 2021;10:711. doi: 10.3390/cells10030711.
    doi: 10.3390/cells10030711pmc: PMC8004686pubmed: 33806940google scholar: lookup
  54. Morén S., Kallberg M., Strom L. Equine uveitis: Outcome and adverse effects after one or two intravitreal low-dose gentamicin injections. Equine Vet. J. 2024;57:160–168. doi: 10.1111/evj.14056.
    doi: 10.1111/evj.14056pmc: PMC11616955pubmed: 38329024google scholar: lookup
  55. Eberhardt C., Amann B., Stangassinger M., Hauck S.M., Deeg C.A. Isolation, characterization and establishment of an equine retinal glial cell line: A prerequisite to investigate the physiological function of Muller cells in the retina. J. Anim. Physiol. Anim. Nutr. 2012;96:260–269. doi: 10.1111/j.1439-0396.2011.01147.x.
    doi: 10.1111/j.1439-0396.2011.01147.xpubmed: 21535230google scholar: lookup
  56. Grosche A., Hauser A., Lepper M.F., Mayo R., von Toerne C., Merl-Pham J., Hauck S.M. The Proteome of Native Adult Müller Glial Cells From Murine Retina. Mol. Cell Proteom. 2016;15:462–480. doi: 10.1074/mcp.M115.052183.
    doi: 10.1074/mcp.M115.052183pmc: PMC4739667pubmed: 26324419google scholar: lookup
  57. Wiśniewski J.R., Zougman A., Nagaraj N., Mann M. Universal sample preparation method for proteome analysis. Nat. Methods. 2009;6:359–362. doi: 10.1038/nmeth.1322.
    doi: 10.1038/nmeth.1322pubmed: 19377485google scholar: lookup
  58. Navarro P., Trevisan-Herraz M., Bonzon-Kulichenko E., Núñez E., Martínez-Acedo P., Pérez-Hernández D., Jorge I., Mesa R., Calvo E., Carrascal M., et al. General Statistical Framework for Quantitative Proteomics by Stable Isotope Labeling. J. Proteome Res. 2014;13:1234–1247. doi: 10.1021/pr4006958.
    doi: 10.1021/pr4006958pubmed: 24512137google scholar: lookup
  59. Benjamini Y., Hochberg Y. Controlling the False Discovery Rate: A Practical and Powerful Approach to Multiple Testing. J. R. Stat. Soc. Ser. B (Methodol.) 1995;57:289–300. doi: 10.1111/j.2517-6161.1995.tb02031.x.
    doi: 10.1111/j.2517-6161.1995.tb02031.xgoogle scholar: lookup
  60. Ehrenhofer M.C., Deeg C.A., Reese S., Liebich H.G., Stangassinger M., Kaspers B. Normal structure and age-related changes of the equine retina. Vet. Ophthalmol. 2002;5:39–47. doi: 10.1046/j.1463-5224.2002.00210.x.
    doi: 10.1046/j.1463-5224.2002.00210.xpubmed: 11940247google scholar: lookup
  61. Woo S.J., Kim Y., Kang H.J., Jung H., Youn D.H., Hong Y., Lee J.J., Hong J.Y. Tuberculous pleural effusion-induced Arg-1(+) macrophage polarization contributes to lung cancer progression via autophagy signaling. Respir. Res. 2024;25:198. doi: 10.1186/s12931-024-02829-8.
    doi: 10.1186/s12931-024-02829-8pmc: PMC11077851pubmed: 38720340google scholar: lookup
  62. Zhu L.W., Li Z., Dong X., Wu H., Cheng Y., Xia S., Bao X., Xu Y., Cao R. Ficolin-A induces macrophage polarization to a novel pro-inflammatory phenotype distinct from classical M1. Cell Commun. Signal. 2024;22:271. doi: 10.1186/s12964-024-01571-4.
    doi: 10.1186/s12964-024-01571-4pmc: PMC11094856pubmed: 38750493google scholar: lookup
  63. Gestal-Mato U., Herhaus L. Autophagy-dependent regulation of MHC-I molecule presentation. J. Cell Biochem. 2024;125:e30416. doi: 10.1002/jcb.30416.
    doi: 10.1002/jcb.30416pubmed: 37126231google scholar: lookup
  64. Nørregaard K.S., Jürgensen H.J., Ingvarsen S.Z., Heltberg S.S., Hagensen C.E., Gårdsvoll H., Madsen D.H., Jensen O.N., Engelholm L.H., Behrendt N. The endocytic receptor uPARAP is a regulator of extracellular thrombospondin-1. Matrix Biol. 2022;111:307–328. doi: 10.1016/j.matbio.2022.07.004.
    doi: 10.1016/j.matbio.2022.07.004pubmed: 35878760google scholar: lookup
  65. Guerder S., Flavell R.A. T-cell activation. Two for T. Curr. Biol. 1995;5:866–868. doi: 10.1016/S0960-9822(95)00175-8.
    doi: 10.1016/S0960-9822(95)00175-8pubmed: 7583143google scholar: lookup
  66. Ishina I.A., Zakharova M.Y., Kurbatskaia I.N., Mamedov A.E., Belogurov A.A., Jr., Gabibov A.G. MHC Class II Presentation in Autoimmunity. Cells. 2023;12:314. doi: 10.3390/cells12020314.
    doi: 10.3390/cells12020314pmc: PMC9856717pubmed: 36672249google scholar: lookup
  67. Sun L., Su Y., Jiao A., Wang X., Zhang B. T cells in health and disease. Signal Transduct. Target. Ther. 2023;8:235. doi: 10.1038/s41392-023-01471-y.
    doi: 10.1038/s41392-023-01471-ypmc: PMC10277291pubmed: 37332039google scholar: lookup
  68. Wilbanks G.A., Streilein J.W. Characterization of suppressor cells in anterior chamber-associated immune deviation (ACAID) induced by soluble antigen. Evidence of two functionally and phenotypically distinct T-suppressor cell populations. Immunology. 1990;71:383–389.
    pmc: PMC1384437pubmed: 1702748
  69. Niederkorn J.Y., Streilein J.W. Alloantigens placed into the anterior chamber of the eye induce specific suppression of delayed-type hypersensitivity but normal cytotoxic T lymphocyte and helper T lymphocyte responses. J. Immunol. 1983;131:2670–2674. doi: 10.4049/jimmunol.131.6.2670.
    doi: 10.4049/jimmunol.131.6.2670pubmed: 6196396google scholar: lookup
  70. Mochizuki M., Sugita S., Kamoi K. Immunological homeostasis of the eye. Prog. Retin. Eye Res. 2013;33:10–27. doi: 10.1016/j.preteyeres.2012.10.002.
    doi: 10.1016/j.preteyeres.2012.10.002pubmed: 23108335google scholar: lookup
  71. Schultz L.M., Czerwinski D.K., Levy R., Levy S. CD81 costimulation skews CAR transduction toward naive T cells. Proc. Natl. Acad. Sci. USA. 2022;119:e1910844119. doi: 10.1073/pnas.1910844119.
    doi: 10.1073/pnas.1910844119pmc: PMC8812682pubmed: 35091467google scholar: lookup
  72. Roets M., Sturgess D., Tran T., Obeysekera M., Perros A., Tung J.P., Flower R., van Zundert A., Dean M. Intraoperative cell salvage: The impact on immune cell numbers. PLoS ONE. 2023;18:e0289177. doi: 10.1371/journal.pone.0289177.
    doi: 10.1371/journal.pone.0289177pmc: PMC10393166pubmed: 37527263google scholar: lookup
  73. McArdel S.L., Terhorst C., Sharpe A.H. Roles of CD48 in regulating immunity and tolerance. Clin. Immunol. 2016;164:10–20. doi: 10.1016/j.clim.2016.01.008.
    doi: 10.1016/j.clim.2016.01.008pmc: PMC4860950pubmed: 26794910google scholar: lookup
  74. Hammer Q., Perica K., Mbofung R.M., van Ooijen H., Martin K.E., Momayyezi P., Varady E., Pan Y., Jelcic M., Groff B., et al. Genetic ablation of adhesion ligands mitigates rejection of allogeneic cellular immunotherapies. Cell Stem Cell. 2024;31:1376–1386.e1378. doi: 10.1016/j.stem.2024.06.011.
    doi: 10.1016/j.stem.2024.06.011pmc: PMC12718542pubmed: 38981470google scholar: lookup
  75. Croft M., Bradley L.M., Swain S.L. Naive versus memory CD4 T cell response to antigen. Memory cells are less dependent on accessory cell costimulation and can respond to many antigen-presenting cell types including resting B cells. J. Immunol. 1994;152:2675–2685. doi: 10.4049/jimmunol.152.6.2675.
    doi: 10.4049/jimmunol.152.6.2675pubmed: 7908301google scholar: lookup
  76. Kamihira T., Shimoda S., Harada K., Kawano A., Handa M., Baba E., Tsuneyama K., Nakamura M., Ishibashi H., Nakanuma Y., et al. Distinct costimulation dependent and independent autoreactive T-cell clones in primary biliary cirrhosis. Gastroenterology. 2003;125:1379–1387. doi: 10.1016/j.gastro.2003.07.013.
    doi: 10.1016/j.gastro.2003.07.013pubmed: 14598254google scholar: lookup
  77. Scholz C., Patton K.T., Anderson D.E., Freeman G.J., Hafler D.A. Expansion of autoreactive T cells in multiple sclerosis is independent of exogenous B7 costimulation. J. Immunol. 1998;160:1532–1538. doi: 10.4049/jimmunol.160.3.1532.
    doi: 10.4049/jimmunol.160.3.1532pubmed: 9570577google scholar: lookup
  78. Markovic-Plese S., Cortese I., Wandinger K.P., McFarland H.F., Martin R. CD4+CD28- costimulation-independent T cells in multiple sclerosis. J. Clin. Investig. 2001;108:1185–1194. doi: 10.1172/JCI200112516.
    doi: 10.1172/JCI200112516pmc: PMC209525pubmed: 11602626google scholar: lookup
  79. Kawano A., Shimoda S., Kamihira T., Ishikawa F., Niiro H., Soejima Y., Taketomi A., Maehara Y., Nakamura M., Komori A., et al. Peripheral tolerance and the qualitative characteristics of autoreactive T cell clones in primary biliary cirrhosis. J. Immunol. 2007;179:3315–3324. doi: 10.4049/jimmunol.179.5.3315.
    doi: 10.4049/jimmunol.179.5.3315pubmed: 17709548google scholar: lookup
  80. Polak D., Bohle B. Neutrophils-typical atypical antigen presenting cells? Immunol. Lett. 2022;247:52–58. doi: 10.1016/j.imlet.2022.04.007.
    doi: 10.1016/j.imlet.2022.04.007pubmed: 35577002google scholar: lookup
  81. Polak D., Samadi N., Vizzardelli C., Sánchez Acosta G., Rosskopf S., Steinberger P., Jahn-Schmid B., Bohle B. Neutrophils promote T-cell mediated inflammation in allergy. J. Allergy Clin. Immunol. 2019;143:1923–1925.e1923. doi: 10.1016/j.jaci.2018.11.035.
    doi: 10.1016/j.jaci.2018.11.035pubmed: 30578884google scholar: lookup
  82. Monroy-Mérida G., Guzmán-Beltrán S., Hernández F., Santos-Mendoza T., Bobadilla K. High Glucose Concentrations Impair the Processing and Presentation of Mycobacterium tuberculosis Antigens In Vitro. Biomolecules. 2021;11:1763. doi: 10.3390/biom11121763.
    doi: 10.3390/biom11121763pmc: PMC8698639pubmed: 34944407google scholar: lookup
  83. Yang X., Wang Z., Xie S., Liang Z., Wei N., Pan J., Zhao Y., Cao R. JEV infection leads to dysfunction of lysosome by downregulating the expression of LAMP1 and LAMP2. Vet. Microbiol. 2024;295:110150. doi: 10.1016/j.vetmic.2024.110150.
    doi: 10.1016/j.vetmic.2024.110150pubmed: 38861863google scholar: lookup
  84. Guerriero J.L. Macrophages: Their Untold Story in T Cell Activation and Function. Int. Rev. Cell Mol. Biol. 2019;342:73–93. doi: 10.1016/bs.ircmb.2018.07.001.
    doi: 10.1016/bs.ircmb.2018.07.001pubmed: 30635094google scholar: lookup
  85. Canè S., Geiger R., Bronte V. The roles of arginases and arginine in immunity. Nat. Rev. Immunol. 2024 doi: 10.1038/s41577-024-01098-2.
    doi: 10.1038/s41577-024-01098-2pubmed: 39420221google scholar: lookup
  86. Menjivar R.E., Nwosu Z.C., Du W., Donahue K.L., Hong H.S., Espinoza C., Brown K., Velez-Delgado A., Yan W., Lima F., et al. Arginase 1 is a key driver of immune suppression in pancreatic cancer. eLife. 2023;12:e80721. doi: 10.7554/eLife.80721.
    doi: 10.7554/eLife.80721pmc: PMC10260021pubmed: 36727849google scholar: lookup
  87. Chen M., Copland D.A., Zhao J., Liu J., Forrester J.V., Dick A.D., Xu H. Persistent Inflammation Subverts Thrombospondin-1-Induced Regulation of Retinal Angiogenesis and Is Driven by CCR2 Ligation. Am. J. Pathol. 2012;180:235–245. doi: 10.1016/j.ajpath.2011.09.020.
    doi: 10.1016/j.ajpath.2011.09.020pubmed: 22067906google scholar: lookup
  88. Touri K., Belguendouz H., Medjeber O., Djeraba Z., Lahmar K., Touil-Boukoffa C. Propolis modulates NOS2/arginase-1 pathway in tropomyosin-induced experimental autoimmune uveitis. Inflammopharmacology. 2018;26:1293–1303. doi: 10.1007/s10787-018-0487-8.
    doi: 10.1007/s10787-018-0487-8pubmed: 29752572google scholar: lookup
  89. Zhang W., Baban B., Rojas M., Tofigh S., Virmani S.K., Patel C., Behzadian M.A., Romero M.J., Caldwell R.W., Caldwell R.B. Arginase activity mediates retinal inflammation in endotoxin-induced uveitis. Am. J. Pathol. 2009;175:891–902. doi: 10.2353/ajpath.2009.081115.
    doi: 10.2353/ajpath.2009.081115pmc: PMC2716983pubmed: 19590038google scholar: lookup
  90. Patel C., Rojas M., Narayanan S.P., Zhang W., Xu Z., Lemtalsi T., Jittiporn K., Caldwell R.W., Caldwell R.B. Arginase as a mediator of diabetic retinopathy. Front. Immunol. 2013;4:173. doi: 10.3389/fimmu.2013.00173.
    doi: 10.3389/fimmu.2013.00173pmc: PMC3699717pubmed: 23840196google scholar: lookup
  91. Clemente S.G., van Waarde A., Antunes F.I., Dömling A., Elsinga H.P. Arginase as a Potential Biomarker of Disease Progression: A Molecular Imaging Perspective. Int. J. Mol. Sci. 2020;21:5291. doi: 10.3390/ijms21155291.
    doi: 10.3390/ijms21155291pmc: PMC7432485pubmed: 32722521google scholar: lookup
  92. Han X., Wang D., Yang L., Wang N., Shen J., Wang J., Zhang L., Chen L., Gao S., Zong W.X., et al. Activation of polyamine catabolism promotes glutamine metabolism and creates a targetable vulnerability in lung cancer. Proc. Natl. Acad. Sci. USA. 2024;121:e2319429121. doi: 10.1073/pnas.2319429121.
    doi: 10.1073/pnas.2319429121pmc: PMC10990097pubmed: 38513095google scholar: lookup
  93. Murray Stewart T., Dunston T.T., Woster P.M., Casero R.A., Jr. Polyamine catabolism and oxidative damage. J. Biol. Chem. 2018;293:18736–18745. doi: 10.1074/jbc.TM118.003337.
    doi: 10.1074/jbc.TM118.003337pmc: PMC6290137pubmed: 30333229google scholar: lookup
  94. Wagner A., Wang C., Fessler J., DeTomaso D., Avila-Pacheco J., Kaminski J., Zaghouani S., Christian E., Thakore P., Schellhaass B., et al. Metabolic modeling of single Th17 cells reveals regulators of autoimmunity. Cell. 2021;184:4168–4185.e4121. doi: 10.1016/j.cell.2021.05.045.
    doi: 10.1016/j.cell.2021.05.045pmc: PMC8621950pubmed: 34216539google scholar: lookup
  95. Wu R., Chen X., Kang S., Wang T., Gnanaprakasam J.R., Yao Y., Liu L., Fan G., Burns M.R., Wang R. De novo synthesis and salvage pathway coordinately regulate polyamine homeostasis and determine T cell proliferation and function. Sci. Adv. 2020;6:eabc4275. doi: 10.1126/sciadv.abc4275.
    doi: 10.1126/sciadv.abc4275pmc: PMC7744078pubmed: 33328226google scholar: lookup
  96. Pichavaram P., Palani C.D., Patel C., Xu Z., Shosha E., Fouda A.Y., Caldwell R.B., Narayanan S.P. Targeting Polyamine Oxidase to Prevent Excitotoxicity-Induced Retinal Neurodegeneration. Front. Neurosci. 2019;12:956. doi: 10.3389/fnins.2018.00956.
    doi: 10.3389/fnins.2018.00956pmc: PMC6335392pubmed: 30686964google scholar: lookup
  97. Pernet V., Bourgeois P., Di Polo A. A role for polyamines in retinal ganglion cell excitotoxic death. J. Neurochem. 2007;103:1481–1490. doi: 10.1111/j.1471-4159.2007.04843.x.
    doi: 10.1111/j.1471-4159.2007.04843.xpubmed: 17714450google scholar: lookup
  98. Wood P.L., Khan M.A., Moskal J.R. The concept of “aldehyde load” in neurodegenerative mechanisms: Cytotoxicity of the polyamine degradation products hydrogen peroxide, acrolein, 3-aminopropanal, 3-acetamidopropanal and 4-aminobutanal in a retinal ganglion cell line. Brain Res. 2007;1145:150–156. doi: 10.1016/j.brainres.2006.10.004.
    doi: 10.1016/j.brainres.2006.10.004pubmed: 17362887google scholar: lookup
  99. Luger D., Silver P.B., Tang J., Cua D., Chen Z., Iwakura Y., Bowman E.P., Sgambellone N.M., Chan C.-C., Caspi R.R. Either a Th17 or a Th1 effector response can drive autoimmunity: Conditions of disease induction affect dominant effector category. J. Exp. Med. 2008;205:799–810. doi: 10.1084/jem.20071258.
    doi: 10.1084/jem.20071258pmc: PMC2292220pubmed: 18391061google scholar: lookup
  100. Zhang C., Liu X., Gu C., Su Y., Lv J., Liu Y., Gao Y., Chen H., Xu N., Xiao J., et al. Histone deacetylases facilitate Th17-cell differentiation and pathogenicity in autoimmune uveitis via CDK6/ID2 axis. J. Adv. Res. p. 2024. in press .
    doi: 10.1016/j.jare.2024.07.029pubmed: 39107200google scholar: lookup
  101. Regan D.P., Aarnio M.C., Davis W.S., Carmichael K.P., Vandenplas M.L., Lauderdale J.D., Moore P.A. Characterization of cytokines associated with Th17 cells in the eyes of horses with recurrent uveitis. Vet. Ophthalmol. 2012;15:145–152. doi: 10.1111/j.1463-5224.2011.00951.x.
    doi: 10.1111/j.1463-5224.2011.00951.xpubmed: 22051225google scholar: lookup
  102. Nilsson I., Bahram F., Li X., Gualandi L., Koch S., Jarvius M., Söderberg O., Anisimov A., Kholová I., Pytowski B., et al. VEGF receptor 2/-3 heterodimers detected in situ by proximity ligation on angiogenic sprouts. EMBO J. 2010;29:1377–1388. doi: 10.1038/emboj.2010.30.
    doi: 10.1038/emboj.2010.30pmc: PMC2868571pubmed: 20224550google scholar: lookup
  103. Durré T., Morfoisse F., Erpicum C., Ebroin M., Blacher S., García-Caballero M., Deroanne C., Louis T., Balsat C., Van de Velde M., et al. uPARAP/Endo180 receptor is a gatekeeper of VEGFR-2/VEGFR-3 heterodimerisation during pathological lymphangiogenesis. Nat. Commun. 2018;9:5178. doi: 10.1038/s41467-018-07514-1.
    doi: 10.1038/s41467-018-07514-1pmc: PMC6281649pubmed: 30518756google scholar: lookup
  104. Kaur S., Roberts D.D. Emerging functions of thrombospondin-1 in immunity. Semin. Cell Dev. Biol. 2024;155:22–31. doi: 10.1016/j.semcdb.2023.05.008.
    doi: 10.1016/j.semcdb.2023.05.008pmc: PMC10684827pubmed: 37258315google scholar: lookup
  105. Sheibani N., Sorenson C.M., Cornelius L.A., Frazier W.A. Thrombospondin-1, a Natural Inhibitor of Angiogenesis, Is Present in Vitreous and Aqueous Humor and Is Modulated by Hyperglycemia. Biochem. Biophys. Res. Commun. 2000;267:257–261. doi: 10.1006/bbrc.1999.1903.
    doi: 10.1006/bbrc.1999.1903pubmed: 10623607google scholar: lookup
  106. Liu B., Yang H., Song Y.S., Sorenson C.M., Sheibani N. Thrombospondin-1 in vascular development, vascular function, and vascular disease. Semin. Cell Dev. Biol. 2024;155:32–44. doi: 10.1016/j.semcdb.2023.07.011.
    doi: 10.1016/j.semcdb.2023.07.011pmc: PMC10811293pubmed: 37507331google scholar: lookup
  107. Wang S., Gottlieb J.L., Sorenson C.M., Sheibani N. Modulation of Thrombospondin 1 and Pigment Epithelium–Derived Factor Levels in Vitreous Fluid of Patients With Diabetes. Arch. Ophthalmol. 2009;127:507–513. doi: 10.1001/archophthalmol.2009.53.
    doi: 10.1001/archophthalmol.2009.53pmc: PMC2819322pubmed: 19365032google scholar: lookup
  108. Sorenson C.M., Wang S., Gendron R., Paradis H., Sheibani N. Thrombospondin-1 Deficiency Exacerbates the Pathogenesis of Diabetic Retinopathy. J. Diabetes Metab. 2013;((Suppl. S12)) doi: 10.4172/2155-6156.S12-005.
    doi: 10.4172/2155-6156.S12-005pmc: PMC3818794pubmed: 24224119google scholar: lookup
  109. Deeg C.A., Eberhardt C., Hofmaier F., Amann B., Hauck S.M. Osteopontin and fibronectin levels are decreased in vitreous of autoimmune uveitis and retinal expression of both proteins indicates ECM re-modeling. PLoS ONE. 2011;6:e27674. doi: 10.1371/journal.pone.0027674.
    doi: 10.1371/journal.pone.0027674pmc: PMC3237414pubmed: 22194789google scholar: lookup
  110. Deeg C.A., Altmann F., Hauck S.M., Schoeffmann S., Amann B., Stangassinger M., Ueffing M. Down-regulation of pigment epithelium-derived factor in uveitic lesion associates with focal vascular endothelial growth factor expression and breakdown of the blood-retinal barrier. Proteomics. 2007;7:1540–1548. doi: 10.1002/pmic.200600795.
    doi: 10.1002/pmic.200600795pubmed: 17407186google scholar: lookup
  111. Zipplies J.K., Hauck S.M., Schoeffmann S., Amann B., van der Meijden C.H., Stangassinger M., Ueffing M., Deeg C.A. Kininogen in autoimmune uveitis: Decrease in peripheral blood stream versus increase in target tissue. Investig. Ophthalmol. Vis. Sci. 2010;51:375–382. doi: 10.1167/iovs.09-4094.
    doi: 10.1167/iovs.09-4094pubmed: 19696180google scholar: lookup
  112. Soriano-Romaní L., Mir F.A., Singh N., Chin I., Hafezi-Moghadam A., Masli S. CD47 Binding on Vascular Endothelial Cells Inhibits IL-17-Mediated Leukocyte Adhesion. Int. J. Mol. Sci. 2022;23:5705. doi: 10.3390/ijms23105705.
    doi: 10.3390/ijms23105705pmc: PMC9146020pubmed: 35628515google scholar: lookup
  113. Zamiri P., Masli S., Kitaichi N., Taylor A.W., Streilein J.W. Thrombospondin Plays a Vital Role in the Immune Privilege of the Eye. Investig. Ophthalmol. Vis. Sci. 2005;46:908–919. doi: 10.1167/iovs.04-0362.
    doi: 10.1167/iovs.04-0362pubmed: 15728547google scholar: lookup
  114. Turpie B., Yoshimura T., Gulati A., Rios J.D., Dartt D.A., Masli S. Sjögren’s syndrome-like ocular surface disease in thrombospondin-1 deficient mice. Am. J. Pathol. 2009;175:1136–1147. doi: 10.2353/ajpath.2009.081058.
    doi: 10.2353/ajpath.2009.081058pmc: PMC2731132pubmed: 19700744google scholar: lookup
  115. Sheikh H., Yarwood H., Ashworth A., Isacke C.M. Endo180, an endocytic recycling glycoprotein related to the macrophage mannose receptor is expressed on fibroblasts, endothelial cells and macrophages and functions as a lectin receptor. Pt 6J. Cell Sci. 2000;113:1021–1032. doi: 10.1242/jcs.113.6.1021.
    doi: 10.1242/jcs.113.6.1021pubmed: 10683150google scholar: lookup
  116. Gucciardo F., Pirson S., Baudin L., Lebeau A., Noël A. uPARAP/Endo180: A multifaceted protein of mesenchymal cells. Cell Mol. Life Sci. 2022;79:255. doi: 10.1007/s00018-022-04249-7.
    doi: 10.1007/s00018-022-04249-7pmc: PMC9033714pubmed: 35460056google scholar: lookup
  117. López-Guisa J.M., Cai X., Collins S.J., Yamaguchi I., Okamura D.M., Bugge T.H., Isacke C.M., Emson C.L., Turner S.M., Shankland S.J., et al. Mannose Receptor 2 Attenuates Renal Fibrosis. J. Am. Soc. Nephrol. 2012;23:236–251. doi: 10.1681/ASN.2011030310.
    doi: 10.1681/ASN.2011030310pmc: PMC3269177pubmed: 22095946google scholar: lookup
  118. Nørregaard K.S., Krigslund O., Behrendt N., Engelholm L.H., Jürgensen H.J. The collagen receptor uPARAP/Endo180 regulates collectins through unique structural elements in its FNII domain. J. Biol. Chem. 2020;295:9157–9170. doi: 10.1074/jbc.RA120.013710.
    doi: 10.1074/jbc.RA120.013710pmc: PMC7335807pubmed: 32424040google scholar: lookup
  119. Jürgensen H.J., Nørregaard K.S., Sibree M.M., Santoni-Rugiu E., Madsen D.H., Wassilew K., Krustrup D., Garred P., Bugge T.H., Engelholm L.H., et al. Immune regulation by fibroblasts in tissue injury depends on uPARAP-mediated uptake of collectins. J. Cell Biol. 2019;218:333–349. doi: 10.1083/jcb.201802148.
    doi: 10.1083/jcb.201802148pmc: PMC6314555pubmed: 30366943google scholar: lookup
  120. Nauser C.L., Howard M.C., Fanelli G., Farrar C.A., Sacks S. Collectin-11 (CL-11) Is a Major Sentinel at Epithelial Surfaces and Key Pattern Recognition Molecule in Complement-Mediated Ischaemic Injury. Front. Immunol. 2018;9:2023. doi: 10.3389/fimmu.2018.02023.
    doi: 10.3389/fimmu.2018.02023pmc: PMC6136055pubmed: 30237800google scholar: lookup
  121. Asanuma Y., Nozawa K., Matsushita M., Kusaoi M., Abe Y., Yamaji K., Tamura N. Critical role of lectin pathway mediated by MBL-associated serine proteases in complement activation for the pathogenesis in systemic lupus erythematosus. Heliyon. 2023;9:e19072. doi: 10.1016/j.heliyon.2023.e19072.
    doi: 10.1016/j.heliyon.2023.e19072pmc: PMC10457435pubmed: 37636359google scholar: lookup
  122. Dobó J., Kocsis A., Farkas B., Demeter F., Cervenak L., Gál P. The Lectin Pathway of the Complement System-Activation, Regulation, Disease Connections and Interplay with Other (Proteolytic) Systems. Int. J. Mol. Sci. 2024;25:1566. doi: 10.3390/ijms25031566.
    doi: 10.3390/ijms25031566pmc: PMC10855846pubmed: 38338844google scholar: lookup
  123. Kalia N., Singh J., Kaur M. The ambiguous role of mannose-binding lectin (MBL) in human immunity. Open Med. 2021;16:299–310. doi: 10.1515/med-2021-0239.
    doi: 10.1515/med-2021-0239pmc: PMC7917369pubmed: 33681468google scholar: lookup
  124. Jack D.L., Read R.C., Tenner A.J., Frosch M., Turner M.W., Klein N.J. Mannose-binding lectin regulates the inflammatory response of human professional phagocytes to Neisseria meningitidis serogroup B. J. Infect. Dis. 2001;184:1152–1162. doi: 10.1086/323803.
    doi: 10.1086/323803pubmed: 11598838google scholar: lookup
  125. Dean M.M., Flower R.L., Eisen D.P., Minchinton R.M., Hart D.N., Vuckovic S. Mannose-binding lectin deficiency influences innate and antigen-presenting functions of blood myeloid dendritic cells. Immunology. 2011;132:296–305. doi: 10.1111/j.1365-2567.2010.03365.x.
    doi: 10.1111/j.1365-2567.2010.03365.xpmc: PMC3050452pubmed: 21091907google scholar: lookup
  126. Kambulyan L., Chopikyan A., Iritsyan S., Mkhitaryan A., Hovakimyan A. The Role of Complement System’s C3 and C4 Fractions in the Pathogenesis of Uveitis. Ocul. Immunol. Inflamm. 2024;32:2179–2184. doi: 10.1080/09273948.2024.2337838.
    doi: 10.1080/09273948.2024.2337838pubmed: 38588040google scholar: lookup
  127. Zipplies J.K., Kirschfink M., Amann B., Hauck S.M., Stangassinger M., Deeg C.A. Complement factor B expression profile in a spontaneous uveitis model. Immunobiology. 2010;215:949–955. doi: 10.1016/j.imbio.2010.02.003.
    doi: 10.1016/j.imbio.2010.02.003pubmed: 20334949google scholar: lookup
  128. Jenkins L., Jungwirth U., Avgustinova A., Iravani M., Mills A., Haider S., Harper J., Isacke C.M. Cancer-Associated Fibroblasts Suppress CD8+ T-cell Infiltration and Confer Resistance to Immune-Checkpoint Blockade. Cancer Res. 2022;82:2904–2917. doi: 10.1158/0008-5472.CAN-21-4141.
    doi: 10.1158/0008-5472.CAN-21-4141pmc: PMC9379365pubmed: 35749591google scholar: lookup
  129. Wei C., Mei J., Tang L., Liu Y., Li D., Li M., Zhu X. 1-Methyl-tryptophan attenuates regulatory T cells differentiation due to the inhibition of estrogen-IDO1-MRC2 axis in endometriosis. Cell Death Dis. 2016;7:e2489. doi: 10.1038/cddis.2016.375.
    doi: 10.1038/cddis.2016.375pmc: PMC5260991pubmed: 27906184google scholar: lookup
  130. Terrada C.l., Fisson S., De Kozak Y., Kaddouri M., Lehoang P., Klatzmann D., Salomon B.t.L., Bodaghi B. Regulatory T Cells Control Uveoretinitis Induced by Pathogenic Th1 Cells Reacting to a Specific Retinal Neoantigen1. J. Immunol. 2006;176:7171–7179. doi: 10.4049/jimmunol.176.12.7171.
    doi: 10.4049/jimmunol.176.12.7171pubmed: 16751360google scholar: lookup
  131. Ruggieri S., Frassanito M.A., Dammacco R., Guerriero S. Treg Lymphocytes in Autoimmune Uveitis. Ocul. Immunol. Inflamm. 2012;20:255–261. doi: 10.3109/09273948.2012.681830.
    doi: 10.3109/09273948.2012.681830pubmed: 22564107google scholar: lookup
  132. Yeh S., Li Z., Forooghian F., Hwang F.S., Cunningham M.A., Pantanelli S., Lew J.C., Wroblewski K.K., Vitale S., Nussenblatt R.B. CD4+Foxp3+ T-regulatory cells in noninfectious uveitis. Arch. Ophthalmol. 2009;127:407–413. doi: 10.1001/archophthalmol.2009.32.
    doi: 10.1001/archophthalmol.2009.32pmc: PMC2928652pubmed: 19365016google scholar: lookup
  133. Geijtenbeek T.B., van Vliet S.J., Engering A., t Hart B.A., van Kooyk Y. Self- and nonself-recognition by C-type lectins on dendritic cells. Annu. Rev. Immunol. 2004;22:33–54. doi: 10.1146/annurev.immunol.22.012703.104558.
    doi: 10.1146/annurev.immunol.22.012703.104558pubmed: 15032573google scholar: lookup
  134. Reis E.S.C., Yamasaki S., Brown G.D. Myeloid C-type lectin receptors in innate immune recognition. Immunity. 2024;57:700–717. doi: 10.1016/j.immuni.2024.03.005.
    doi: 10.1016/j.immuni.2024.03.005pubmed: 38599166google scholar: lookup
  135. Wang W., Li T., Xie Z., Zhao J., Zhang Y., Ruan Y., Han B. Integrating single-cell and bulk RNA sequencing data unveils antigen presentation and process-related CAFS and establishes a predictive signature in prostate cancer. J. Transl. Med. 2024;22:57. doi: 10.1186/s12967-023-04807-y.
    doi: 10.1186/s12967-023-04807-ypmc: PMC10789066pubmed: 38221616google scholar: lookup
  136. Ishida K., Nagatake T., Saika A., Kawai S., Node E., Hosomi K., Kunisawa J. Induction of unique macrophage subset by simultaneous stimulation with LPS and IL-4. Front. Immunol. 2023;14:1111729. doi: 10.3389/fimmu.2023.1111729.
    doi: 10.3389/fimmu.2023.1111729pmc: PMC10167635pubmed: 37180123google scholar: lookup
  137. Bansal S., Barathi V.A., Iwata D., Agrawal R. Experimental autoimmune uveitis and other animal models of uveitis: An update. Indian. J. Ophthalmol. 2015;63:211–218. doi: 10.4103/0301-4738.156914.
    doi: 10.4103/0301-4738.156914pmc: PMC4448233pubmed: 25971165google scholar: lookup
  138. Rozanova S., Barkovits K., Nikolov M., Schmidt C., Urlaub H., Marcus K. Quantitative Mass Spectrometry-Based Proteomics: An Overview. Methods Mol. Biol. 2021;2228:85–116. doi: 10.1007/978-1-0716-1024-4_8.
    doi: 10.1007/978-1-0716-1024-4_8pubmed: 33950486google scholar: lookup
  139. Fu J., Yang Q., Luo Y., Zhang S., Tang J., Zhang Y., Zhang H., Xu H., Zhu F. Label-free proteome quantification and evaluation. Brief. Bioinform. 2022;24:bbac477. doi: 10.1093/bib/bbac477.
    doi: 10.1093/bib/bbac477pubmed: 36403090google scholar: lookup
  140. Kong W., Hui H.W.H., Peng H., Goh W.W.B. Dealing with missing values in proteomics data. Proteomics. 2022;22:e2200092. doi: 10.1002/pmic.202200092.
    doi: 10.1002/pmic.202200092pubmed: 36349819google scholar: lookup
  141. Guzman U.H., Martinez-Val A., Ye Z., Damoc E., Arrey T.N., Pashkova A., Renuse S., Denisov E., Petzoldt J., Peterson A.C., et al. Ultra-fast label-free quantification and comprehensive proteome coverage with narrow-window data-independent acquisition. Nat. Biotechnol. 2024;42:1855–1866. doi: 10.1038/s41587-023-02099-7.
    doi: 10.1038/s41587-023-02099-7pmc: PMC11631760pubmed: 38302753google scholar: lookup
  142. Zhang F., Shan S., Fu C., Guo S., Liu C., Wang S. Advanced Mass Spectrometry-Based Biomarker Identification for Metabolomics of Diabetes Mellitus and Its Complications. Molecules. 2024;29:2530. doi: 10.3390/molecules29112530.
    doi: 10.3390/molecules29112530pmc: PMC11173766pubmed: 38893405google scholar: lookup

Citations

This article has been cited 2 times.
  1. Li R, Needham SR, Kraev I, Hristova M, Lange S. Extracellular vesicle signatures from eye lavage as novel non-invasive biomarkers for hypoxic ischaemic insult-findings from a neonatal mouse model.. Front Med Technol 2025;7:1715676.
    doi: 10.3389/fmedt.2025.1715676pubmed: 41488750google scholar: lookup
  2. Tan R, Wei X, Zhong J, Wang Y, Yu Q. Analysis of Differentially Expressed Proteins Involved in Shrimp and Crab Allergies.. J Clin Lab Anal 2025 Jun;39(12):e70053.
    doi: 10.1002/jcla.70053pubmed: 40366057google scholar: lookup
Subscribe to our newsletter
Join 99,002 horse owners like you who receive our email updates on horse health and nutrition.